France renews its simplified anti-gift conventions – what life sciences companies operating in France need to know
France enforces one of Europe's strictest anti-gift regimes, broadly prohibiting any benefit to healthcare professionals, in particular. Within this framework, simplified conventions offer a practical derogation — allowing companies to bundle hospitality declarations into a single filing. These conventions have just been renewed for another two years, with notable developments: COMIDENT (dental sector) joins as a signatory and a new two-month deadline applies for participant list submissions for certain types of convention.
5 de 9 Publications
BGH restricts the granting of early payment discounts on prescription drugs
Digitisation in hospitals: Data protection as an obstacle or opportunity in Germany?
Hospitals: Increasing demands on IT security
Increasing risk of attacks from cyberspace
Advising Apollo Therapeutics on $145 million financing
Return to work: key issues for life sciences
Licensing out: Try not to get benched
IP: Licensing and insolvency
Conférences et Webinars
Retrouvez les analyses de nos experts sur les dernières questions juridiques.
Voir tous les évènements
France renews its simplified anti-gift conventions – what life sciences companies operating in France need to know
France enforces one of Europe's strictest anti-gift regimes, broadly prohibiting any benefit to healthcare professionals, in particular. Within this framework, simplified conventions offer a practical derogation — allowing companies to bundle hospitality declarations into a single filing. These conventions have just been renewed for another two years, with notable developments: COMIDENT (dental sector) joins as a signatory and a new two-month deadline applies for participant list submissions for certain types of convention.
5 de 9 Publications
BGH restricts the granting of early payment discounts on prescription drugs
Digitisation in hospitals: Data protection as an obstacle or opportunity in Germany?
Hospitals: Increasing demands on IT security
Increasing risk of attacks from cyberspace
Advising Apollo Therapeutics on $145 million financing
Return to work: key issues for life sciences
Licensing out: Try not to get benched
IP: Licensing and insolvency